mergers & acquisitions
Prolight Diagnostics to Acquire UK Point-of-Care Firm Psyros Diagnostics for $7.1M
Psyros said its single-molecule counting technology would enable multiplexing and the measurement of biomarkers at femtomolar concentrations in 10 minutes or less.
The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.
Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm
Project Beacon COVID-19 was started by F-Prime Capital, GV, and the Broad Institute to help implement COVID-19 testing in Massachusetts and its environs.
SQI to Acquire Precision Biomonitoring SARS-CoV-2 Testing Business, Technology
The deal includes the Canadian distribution rights to Biomeme's SARS-CoV-2 Real-Time RT-PCR Test, as well as Precision's TripleLock diagnostic technology.
More than 70 mergers and acquisitions occurred throughout the year, with four deals each surpassing $1 billion in valuations.Â
Dec 23, 2021
Quidel to Acquire Ortho Clinical Diagnostics for $6B
Dec 14, 2021
Quest Diagnostics Acquires LabTech Diagnostics
Nov 22, 2021
Cancer Dx Firms ACT Genomics, Sanomics Merge
Oct 27, 2021